Gonorrhea Test ResistancePlus GC Granted Breakthrough Device Status
The FDA has granted Breakthrough Device designation to ResistancePlus GC,, a test that detects ciprofloxacin susceptibility.
Gonorrhea
Bexsero Vaccine Has Potential for Cross-Protection Against Gonorrhea
Meningococcal vaccine antigens may generate an immune response that recognizes gonococcal proteins.
Zoliflodacin: Promising New Treatment for Urogenital Gonorrhea
Zoliflodacin was effective in treating gonococcal urogenital and rectal infections, but less effective in the treatment of pharyngeal gonorrhea.
Gepotidacin Shows Potential in Treating Resistant Neisseria Gonorrhoeae
Gepotidacin, a novel triazaacenaphthelene bacterial type II topoisomerase inhibitor shows potential in treating resistant Neisseria gonorrhoeae.
CDC: Increase in Rate of STDs for Fourth Consecutive Year in the United States
Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017.
Point-of-Care Molecular Test Effectively Detects Chlamydia, Gonorrhea
A new point-of-care molecular test for CT and NG has the same accuracy as conventional nucleic acid amplification tests in certain settings.
CDC Report on Recommendation Adherence in Uncomplicated Gonorrhea Treatment
Improving provider adherence to treatment recommendations for antibiotic use across the full spectrum of healthcare settings is an integral part of a comprehensive approach to combating the emergence of antimicrobial-resistant gonorrhea.
Doxycycline Post-Exposure Prophylaxis May Prevent STIs in High-Risk MSM
In the future, doxycycline post-exposure prophylaxis might become an effective addition to a combined intervention approach to reduce the high rate of STIs in PrEP users.
Marijuana, Alcohol Intervention May Help to Reduce STIs Among Adolescents
Behavioral interventions that include sexual risk reduction combined with alcohol- and cannabis-focused elements are effective in reducing STI incidence among adolescents.
Antibiotic-Resistant Gonorrhea: Prevention Strategies for a Growing Threat
Learn about drugs in the pipeline for treatment-resistant gonorrhea.
